Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Polyvinyl alcohol adverse reaction |
Causative agent (attribute) |
True |
Polyvinyl alcohol |
Inferred relationship |
Some |
1 |
Allergy to polyvinyl alcohol (finding) |
Causative agent (attribute) |
False |
Polyvinyl alcohol |
Inferred relationship |
Some |
|
Product containing polyvinyl alcohol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Polyvinyl alcohol |
Inferred relationship |
Some |
1 |
Polyvinyl alcohol 1.4% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Polyvinyl alcohol |
Inferred relationship |
Some |
|
Product containing precisely polyvinyl alcohol 14 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Polyvinyl alcohol |
Inferred relationship |
Some |
|
Polyvinyl alcohol 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Polyvinyl alcohol |
Inferred relationship |
Some |
|
Naphazoline hydrochloride + polyvinyl alcohol + zinc sulfate 0.02%wv/0.25%wv/0.25%wv drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Polyvinyl alcohol |
Inferred relationship |
Some |
|
Allergy to polyvinyl alcohol (finding) |
Causative agent (attribute) |
True |
Polyvinyl alcohol |
Inferred relationship |
Some |
1 |
Polyvinyl alcohol 1.4% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Polyvinyl alcohol |
Inferred relationship |
Some |
|
Polyvinyl alcohol 10 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Polyvinyl alcohol |
Inferred relationship |
Some |
1 |
Polyvinyl alcohol 10 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Polyvinyl alcohol |
Inferred relationship |
Some |
1 |
Product containing precisely polyvinyl alcohol 14 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Polyvinyl alcohol |
Inferred relationship |
Some |
1 |
Product containing precisely polyvinyl alcohol 14 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Polyvinyl alcohol |
Inferred relationship |
Some |
1 |
Polyvinyl alcohol 1.4% conventional release eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Polyvinyl alcohol |
Inferred relationship |
Some |
1 |
Polyvinyl alcohol 1.4% conventional release eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Polyvinyl alcohol |
Inferred relationship |
Some |
1 |
Product containing polyvinyl alcohol in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Polyvinyl alcohol |
Inferred relationship |
Some |
1 |
Product containing only polyvinyl alcohol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Polyvinyl alcohol |
Inferred relationship |
Some |
1 |
Polyvinyl alcohol only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Polyvinyl alcohol |
Inferred relationship |
Some |
1 |
Product containing precisely polyvinyl alcohol 14 microliter/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Polyvinyl alcohol |
Inferred relationship |
Some |
1 |
Product containing precisely polyvinyl alcohol 14 microliter/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Polyvinyl alcohol |
Inferred relationship |
Some |
1 |
Naphazoline- and polyvinyl alcohol- and zinc sulfate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Polyvinyl alcohol |
Inferred relationship |
Some |
3 |
Product containing only naphazoline and polyvinyl alcohol and zinc sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Polyvinyl alcohol |
Inferred relationship |
Some |
3 |
Polyvinyl alcohol- and povidone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Polyvinyl alcohol |
Inferred relationship |
Some |
2 |
Polyvinyl alcohol and povidone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Polyvinyl alcohol |
Inferred relationship |
Some |
2 |
Product containing polyvinyl alcohol and povidone in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Polyvinyl alcohol |
Inferred relationship |
Some |
2 |
Polyvinyl alcohol 14 mg/mL and povidone 6 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Polyvinyl alcohol |
Inferred relationship |
Some |
2 |
Polyvinyl alcohol 14 mg/mL and povidone 6 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Polyvinyl alcohol |
Inferred relationship |
Some |
2 |
Polyvinyl alcohol and povidone only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Polyvinyl alcohol |
Inferred relationship |
Some |
2 |